English
  • Ruxolitinib

    Ruxolitinib

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Ruxolitinib Myelofibrosis Novartis Julaị 6, 2024
    ajujunkọwa
  • Relugolix

    Relugolix

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Relugolix Ọrịa prostate Takeda na ASKA Ọnwa Mbụ 24, 2024
    ajujunkọwa
  • Rimegepant

    Rimegepant

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Rimegepant Isi ọwụwa migraine Biohaven Febụwarị 22, 2031

     

    ajujunkọwa
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 Antineoplastic N'ime ụlọ      
    ajujunkọwa
  • Ribociclib 1374639-75-4

    Ribociclib 1374639-75-4

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Ribociclib 1374639-75-4 HR-positive, HER2-adịghị mma Andvance ormetastaticbreast Cancers Novartis
    Ngwa ahịa ọgwụ    		 Ọnwa Isii 27, 2028
    ajujunkọwa
  • Rivaroxaban

    Rivaroxaban

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Rivaroxaban Ọgwụ mgbochi N'ime ụlọ TDP    
    ajujunkọwa
  • Rosuvastatin Calcium

    Calcium nke rosuvastatin

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Calcium nke rosuvastatin Hypercholesterolemia N'ime ụlọ/CEP 20705 √ CEP2015-240
    ajujunkọwa